A Case Report on Coexisting JAK2 V617F and Calr exon 9 Mutation in Essential Thrombocythemia

被引：0
|
作者：
Rashid, Munazza [1 ]
Ahmed, Rifat Zubair [1 ]
Ahmed, Shariq [2 ]
Nadeem, Muhammad [2 ]
Ahmed, Nuzhat [1 ]
Shamsi, Tahir [2 ]
机构：
[1] Natl Inst Blood Dis & Bone Marrow Transplantat, Dept Postgrad Studies & Res, Karachi, Pakistan
[2] Natl Inst Blood Dis & Bone Marrow Transplantat, Karachi, Pakistan
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] COEXISTING JAK2 AND CALR MUTATIONS IN ESSENTIAL THROMBOCYTHEMIA: CASE REPORT
    Arantes, Regina
    Li, Fernanda
    Seixas, Filipa
    Cunha, Manuel
    Moutinho, Osvaldo
    Pinto-Leite, Rosario
    MEDICINE, 2022, 101 (30)
  • [12] Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential Thrombocythemia
    Usseglio, Fabrice
    Beaufils, Nathalie
    Calleja, Anne
    Raynaud, Sophie
    Gabert, Jean
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (01): : 92 - 98
  • [13] JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis
    Kim, Bo Hyun
    Cho, Young-Uk
    Bae, Mi-Hyun
    Jang, Seongsoo
    Seo, Eul-Ju
    Chi, Hyun-Sook
    Choi, Yunsuk
    Kim, Dae-Young
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    Park, Young-Mi
    Lee, Jong-Keuk
    Park, Chan-Jeoung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (07) : 882 - 888
  • [14] Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome
    Briere, Jean
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2007, 191 (03): : 535 - 548
  • [15] Comparison of clinicopathologic findings according to JAK2 V617F mutation in patients with essential thrombocythemia
    Young-Uk Cho
    Hyun-Sook Chi
    Eun-Hye Lee
    Seongsoo Jang
    Chan-Jeoung Park
    Eul-Ju Seo
    International Journal of Hematology, 2009, 89 : 39 - 44
  • [16] Oral squamous cell carcinoma with essential thrombocythemia and positive JAK2 (V617F) mutation
    Rahman, Kurnia H.
    Surboyo, Meircurius D. C.
    Radithia, Desiana
    Parmadiati, Adiastuti E.
    Wihandono, Asdi
    Ernawati, Diah S.
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2022, 17 (02): : 326 - 331
  • [17] Disappearance of JAK2 V617F mutation in a rapid leukemic transformed essential thrombocythemia patient
    Hsiao, Hui-Hua
    Yang, Wen-Chi
    Liu, Yi-Chang
    Lee, Ching-Ping
    Lin, Sheng-Fung
    LEUKEMIA RESEARCH, 2008, 32 (08) : 1323 - 1324
  • [18] Comparison of clinicopathologic findings according to JAK2 V617F mutation in patients with essential thrombocythemia
    Cho, Young-Uk
    Chi, Hyun-Sook
    Lee, Eun-Hye
    Jang, Seongsoo
    Park, Chan-Jeoung
    Seo, Eul-Ju
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (01) : 39 - 44
  • [19] Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia
    Neupane, Niraj
    Low, Soon K.
    Kharel, Himal
    Bhattarai, Sanket
    Thapa, Sangharsha
    Mahmoud, Amir
    Pokhrel, Nishant B.
    Din, Mohammad Ammad Ud
    Kouides, Peter
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (01) : E26 - E28
  • [20] HLA class I immune editing in JAK2 V617F and CALR exon 9 mutation driven myeloproliferative malignancies
    Ivanova, Milena
    Tsvetkova, Gergana
    Micheva, Iliana
    Lessichkova, Spaska
    Petrova, Zasmina
    Ivanova, Anela
    Madjarova, Galja
    Hadjiev, Evgueniy
    Shivarov, Velizar
    HLA, 2023, 101 (04) : 366 - 367
12345